Form 4 Filing for Edesa Biotech, Inc.

Pardeep Nijhawan, Chief Executive Officer, Director, and 10% Owner of Edesa Biotech, Inc., acquired 5,714 Common Shares on September 1, 2026, at a price of $0.0 per share. This transaction, reported under Form 4, indicates a grant of restricted share units that vested in full upon grant. Following this acquisition, Mr. Nijhawan has a total of 899,100 shares. The filing also details holdings through various entities: 402,702 shares held by Pardeep Medicine Professional Corporation, 32,609 shares by The New Nijhawan Family Trust 2015, 32,013 shares by The Digestive Health Clinic Inc., and 53,104 shares by 1968160Ontario Inc. Mr. Nijhawan disclaims beneficial ownership of shares held by these entities except to the extent of his pecuniary interest.